Pariet gastro health

gastro health
Rabeprazole 20mg (Brand)
35 Tablets Gastro health 87 € Buy Now

Rabeprazole, sold under the brand name Pariet among others, is a medication that decreases stomach acid.[6] It is used to treat peptic ulcer disease, gastroesophageal reflux disease, and excess stomach acid production such as in Zollinger–Ellison syndrome.[6] It may also be used in combination with other medications to treat Helicobacter pylori.[7] Effectiveness is similar to other proton pump inhibitors (PPIs).[8] It is taken by mouth.[6]

Common side effects include constipation, feeling weak, and throat inflammation.[6] Serious side effects may include osteoporosis, low blood magnesium, Clostridium difficile infection, and pneumonia.[6] Use in pregnancy and breastfeeding is of unclear safety.[1] It works by blocking H+/K+-ATPase in the parietal cells of the stomach.[6]

Rabeprazole was patented in 1986, and approved for medical use in 1997.[9] It is available as a generic medication.[7] A month supply in the United Kingdom costs the NHS about GB£1 as of 2019.[7] In the United States the wholesale cost of this amount is about US$11.[10] In 2016, it was the 285th most prescribed medication in the United States with more than a million prescriptions

In general, rabeprazole is fairly well tolerated, even up to five years after clinical trial follow-up.[2] The side effect profile is similar to that of omeprazole.[3] The most common side effects include headache, nausea, and diarrhea.[2] Rare side effects include rashes, flu-like symptoms, and infections (including by the gastrointestinal pathogen Clostridium difficile[18]).[3] Rare instances of rabeprazole-induced liver injury (also known as hepatotoxicity) have been reported. Characteristic proton-pump inhibitor hepatoxicity usually occurs within the first four weeks of starting the medication.[19]

Rabeprazole is associated with elevated serum gastrin levels, which are thought to be dependent upon the degree of CYP2C19 metabolism the drug undergoes. In comparison, rabeprazole is not as significantly metabolized by this enzyme compared to other medications in the same class, like omeprazole.[2] Elevated serum gastrin may be associated with gastric cancer.[20]

Acid suppression via rabeprazole can decrease the absorption of vitamin B12 and magnesium, leading to deficiency.[6]

Very serious side effects have been reported in people taking rabeprazole, but these effects have not been “correlated directly” with the use of rabeprazole.[12] These include Stevens-Johnson syndrome, serious hematological abnormalities, coma, and death.[12] Other possible side effects, common to other PPIs medications in the same class, include bone fractures due to osteoporosis and serious infections with Clostridium difficile